P2Y2 receptor desensitization on single endothelial cells.

Receptor desensitization, or decreased responsiveness of a receptor to agonist stimulation, represents a regulatory process with the potential to have a significant impact on cell behavior. P2Y(2), a G-protein-coupled receptor activated by extracellular nucleotides, undergoes desensitization at many tissues, including the vascular endothelium. Endothelial cells from a variety of vascular beds are normally exposed to extracellular nucleotides released from damaged cells and activated platelets. The purpose of the present study was to compare P2Y(2) receptor desensitization observed in endothelial cells derived from bovine retina, a model of microvascular endothelium, and human umbilical vein endothelial cells (HUVECs), a model of a large blood vessel endothelium. P2Y(2) receptor desensitization was monitored by following changes in UTP-stimulated intracellular free Ca(2 +) in single cells using fura-2 microfluorometry. Both endothelial cell models exhibited desensitization of the P2Y(2) receptor after stimulation with UTP. However, the cells differed in the rate, dependence on agonist concentration, and percentage of maximal desensitization. These results suggest differential mechanisms of P2Y(2) receptor desensitization and favors heterogeneity in extracellular nucleotide activity in endothelial cells according to its vascular bed origin.

[1]  W. Aird,et al.  Spatial and temporal dynamics of the endothelium , 2005, Journal of thrombosis and haemostasis : JTH.

[2]  J. Boeynaems,et al.  Overview of the P2 receptors. , 2005, Seminars in thrombosis and hemostasis.

[3]  V. Trinkaus-Randall,et al.  Modulation of endothelial cell migration by extracellular nucleotides , 2005, Thrombosis and Haemostasis.

[4]  G. Weisman,et al.  Differential agonist-induced desensitization of P2Y2 nucleotide receptors by ATP and UTP , 2000, Molecular and Cellular Biochemistry.

[5]  J. T. Turner,et al.  Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y2 nucleotide receptor , 2000, Molecular and Cellular Biochemistry.

[6]  J. T. Turner,et al.  Functional P2Y2 Nucleotide Receptors Mediate Uridine 5′-Triphosphate–Induced Intimal Hyperplasia in Collared Rabbit Carotid Arteries , 2002, Circulation.

[7]  G. Burnstock.  Purinergic Signaling and Vascular Cell Proliferation and Death , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[8]  G. Desoye,et al.  Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity , 2001, Cell proliferation.

[9]  G. Weisman,et al.  P2Y2 nucleotide receptor signaling in human monocytic cells: Activation, desensitization and coupling to mitogen‐activated protein kinases , 2001, Journal of cellular physiology.

[10]  S. Baruffi,et al.  P2y1 and P2y2 receptor-operated Ca2+ signals in primary cultures of cardiac microvascular endothelial cells. , 2001, Microvascular research.

[11]  S. Ferguson,et al.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.

[12]  Y. Agazie,et al.  Molecular mechanisms of ATP and insulin synergistic stimulation of coronary artery smooth muscle growth. , 2001, American journal of physiology. Heart and circulatory physiology.

[13]  Chih‐Chung Lin,et al.  P2Y2 receptor‐mediated proliferation of C6 glioma cells via activation of Ras/Raf/MEK/MAPK pathway , 2000, British journal of pharmacology.

[14]  H. Rasmussen,et al.  Mechanisms of Na+-K+pump regulation in cardiac myocytes during hyposmolar swelling. , 1999, American journal of physiology. Cell physiology.

[15]  J. T. Turner,et al.  Desensitization of P2Y2receptor-activated transepithelial anion secretion. , 1999, American journal of physiology. Cell physiology.

[16]  J. T. Turner,et al.  Desensitization of P2Y2 receptor-activated transepithelial anion secretion. , 1999, The American journal of physiology.

[17]  A. Farrelly,et al.  Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells. , 1999, American journal of physiology. Heart and circulatory physiology.

[18]  S. Soltoff.  Related Adhesion Focal Tyrosine Kinase and the Epidermal Growth Factor Receptor Mediate the Stimulation of Mitogen-activated Protein Kinase by the G-protein-coupled P2Y2 Receptor , 1998, The Journal of Biological Chemistry.

[19]  M. Fisher,et al.  Characterization of the P2 receptors on the human umbilical vein endothelial cell line ECV304 , 1998, British journal of pharmacology.

[20]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[21]  N. Abbott,et al.  Decline of the calcium response on successive stimulation of a rat brain endothelial cell P2U purinoceptor. , 1998, Acta physiologica Scandinavica.

[22]  G. Burnstock.  The past, present and future of purine nucleotides as signalling molecules , 1997, Neuropharmacology.

[23]  CeciliaGarlanda,et al.  Heterogeneity of Endothelial Cells , 1997 .

[24]  C. Garlanda,et al.  Heterogeneity of endothelial cells. Specific markers. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[25]  H. Ohata,et al.  Confocal imaging analysis of ATP-induced Ca2+ response in individual endothelial cells of the artery in situ. , 1997, The American journal of physiology.

[26]  S. Pirotton,et al.  Endothelial P2-purinoceptors: subtypes and signal transduction. , 1996, Journal of autonomic pharmacology.

[27]  M. Miras-Portugal,et al.  Co‐existence of P2Y‐ and PPADS‐insensitive P2U‐purinoceptors in endothelial cells from adrenal medulla , 1996, British journal of pharmacology.

[28]  K. Malarkey,et al.  Role of receptor desensitization, phosphatase induction and intracellular cyclic AMP in the termination of mitogen-activated protein kinase activity in UTP-stimulated EAhy 926 endothelial cells. , 1996, The Biochemical journal.

[29]  R. Swerlick,et al.  Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. , 1996, Blood.

[30]  M. Gillies,et al.  Electrical resistance and macromolecular permeability of retinal capillary endothelial cells in vitro. , 1995, Current eye research.

[31]  J. T. Turner,et al.  G protein-coupled P2 purinoceptors: from molecular biology to functional responses. , 1995, Trends in pharmacological sciences.

[32]  E. Raspé,et al.  Coexpression of P2Y and P2U receptors on aortic endothelial cells. Comparison of cell localization and signaling pathways. , 1995, Circulation research.

[33]  P. Vigne,et al.  Characterization of the effects of 2‐methylthio‐ATP and 2‐chloro‐ATP on brain capillary endothelial cells: similarities to ADP and differences from ATP , 1994, British journal of pharmacology.

[34]  J. T. Turner,et al.  Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. T. Turner,et al.  Functional expression and photoaffinity labeling of a cloned P2U purinergic receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. van Coevorden,et al.  Effects of adenine nucleotides on the proliferation of aortic endothelial cells. , 1992, Circulation research.

[37]  P. Leff,et al.  Further subclassification of ATP receptors based on agonist studies. , 1991, Trends in pharmacological sciences.

[38]  J. Pearson,et al.  Homologous desensitization of ATP-mediated elevations in cytoplasmic calcium and prostacyclin release in human endothelial cells does not involve protein kinase C. , 1990, The Biochemical journal.

[39]  J. Forrester,et al.  Retinal capillary endothelial cells prefer different substrates for growth and migration. , 1988, Tissue & cell.

[40]  E. Teuscher,et al.  Adenosine nucleotides, adenosine and adenine as angiogenesis factors. , 1985, Biomedica biochimica acta.